Moreover, immunohistochemical analysis of xenograft tumors confirmed that the proliferation marker Ki67-positive cell in the tumor tissue of the CORM-3-treated group was significantly lower than that in the control group, and protein HO-1 expression increased significantly in comparison with the control group (Figure 4(e)). The gene discussed is MKI67; the disease is neoplasm.